Healthcare -
Biotechnology - NASDAQ - US
$ 7.05
-7.18 %
$ 1.12 B
Market Cap
-5.88
P/E
OCUL - REVENUE
Revenue OCUL - Ocular Therapeutix, Inc.
63.7 M
LAST VALUE
11.24%
2 YEAR CAGR
72.05%
5 YEAR CAGR
55.48%
10 YEAR CAGR